课题基金 / 基金详情

项目摘要

项目成果

LLOYD G CANTLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The KL2 Mentored Clinical Scholars Program attracts a diverse group of highly talented junior faculty across multiple disciplines from across Yale University (Schools of Medicine, Nursing, Public Health, Faculty of Arts and Sciences, Engineering and Applied Science) who will pursue careers in T1-T4 translational research. This Program has been extremely successful, attracting 151 Scholars who have authored >5200 publications, have been PIs on 258 NIH grants, and have received a total of $557 million in grant funding. Remarkably, 99% of our KL2 Scholars have attained positions in academia, industry or public health conducting, and often with leadership responsibilities for, clinical and translational research. We aim to build on this success by providing Scholars with individualized, competency-based training in translational research that prepares them to contribute to the learning healthcare system, to advance personalized health, and to address health disparities. This preparation includes training in clinical trials, big data, machine learning, bioinformatics, multidisciplinary translational research, team science, implementation science and community-based participatory research. It also introduces them to regulatory issues, bioethics, Good Clinical Practices, and factors that drive rigor, transparency, and replicability. The KL2 promotes the development of relevant competencies among the Scholars by providing: 1) opportunities to work successfully in complex and diverse multidisciplinary research teams, 2) access to mentorship by senior mentors and recent Clinical Scholars, 3) externships in industry, public health and regulatory agencies, and 4) intensive training in grant-writing and in multidisciplinary team science. To oversee these diverse, highly motivated junior investigators, we have an educational leadership team of: 1) three outstanding investigator mentors who work in different areas of translational research, 2) an experienced Diversity Officer, and 3) an expert in evaluating and dynamically reshaping medical education programs. This leadership team has used feedback from prior Scholars and their mentors to add new initiatives to the already successful program. We expanded our logic model to implement social network analyses to track the activities of the Scholars, and we will expand the curriculum to include a new course. That course will mix Scholars and TL-1 trainees who will work in teams as they get formal training and peer mentoring in a variety of areas such as big data/machine learning, diversity and inclusion, and running a research laboratory. With these additions to an already strong curriculum, we believe that the Yale Mentored Clinical Scholars Program will be ideally positioned to train the next generation of leaders in T1-T4 translational research who will transform healthcare in ways that alleviate the burden of disease and improve health in the US and around the world. The Specific Aims of the KL2 are: Aim 1: The Yale Mentored Clinical Scholars Program: To provide a program comprised of a mentored research experience, coursework, and seminars that are intended to promote the emergence of scientific independence and the career development of talented young T1-T4 translational scientist Scholars. Aim 2: The Yale Masters in Health Science Program: To provide those M.D. Scholars who do not possess an advanced research degree with additional coursework and scholarly activities to qualify for a Masters in Health Science (MHS) to address limitations in their scientific preparation for a research career.
期刊论文(217)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ajpc.2023.100497
发表时间: 2023-06
期刊: AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY
影响因子: 4.1
作者: [Walia, Harneet K, Khosla, Atulya Aman, Saxena, Anshul, Aneni, Ehimen, Ali, Shozab S, Valero-Elizondo, Javier, Cainzos-Achirica, Miguel, Feldman, Theodore, Fialkow, Jonathan, Nasir, Khurram]
通讯作者: Nasir, Khurram
DOI: 10.1016/j.ebcr.2017.09.006
发表时间: 2017
期刊: Epilepsy & behavior case reports
影响因子: --
作者: [Quraishi IH, Benjamin CF, Spencer DD, Blumenfeld H, Alkawadri R]
通讯作者: Alkawadri R
Association Between Sexual Orientation, Mistreatment, and Burnout Among US Medical Students.
美国医学生之间的性取向,虐待和倦怠之间的联系。
DOI: 10.1001/jamanetworkopen.2020.36136
发表时间: 2021-02-01
期刊: JAMA network open
影响因子: 13.8
作者: [Samuels EA, Boatright DH, Wong AH, Cramer LD, Desai MM, Solotke MT, Latimore D, Gross CP]
通讯作者: Gross CP
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept.
与全身性皮质类固醇和依那耐酸的有毒表皮坏死术和同时相关的高炎性综合征的同时治疗。
DOI: 10.1016/j.jdcr.2022.09.009
发表时间: 2022-11
期刊: JAAD case reports
影响因子: --
作者: [Choi, Rachel, Garritano, James, Laird, Mary, Johnston, Margaret, Tkachenko, Elizabeth, Damsky, William, Little, Alicia J, McNiff, Jennifer, Girardi, Michael, Nelson, Caroline A]
通讯作者: Nelson, Caroline A
134
    Spatial Elucidation of Human Acute Kidney Injury and Chronic Kidney Disease using Imaging Mass Cytometry
    • 批准号:
      10701865
    • 项目类别:
    • 资助金额:
      $36.0万
    • 财政年份:
      2022
    • 负责人:
      LLOYD G CANTLEY
    • 依托单位:
    Spatial Elucidation of Human Acute Kidney Injury and Chronic Kidney Disease using Imaging Mass Cytometry
    • 批准号:
      10515143
    • 项目类别:
    • 资助金额:
      $36.0万
    • 财政年份:
      2022
    • 负责人:
      LLOYD G CANTLEY
    • 依托单位:
    Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis
    • 批准号:
      10660959
    • 项目类别:
    • 资助金额:
      $49.17万
    • 财政年份:
      2020
    • 负责人:
      LLOYD G CANTLEY
    • 依托单位:
    Defining the Pathogenesis and Prognosis of Human Acute Interstitial Nephritis
    • 批准号:
      10436991
    • 项目类别:
    • 资助金额:
      $52.88万
    • 财政年份:
      2020
    • 负责人:
      LLOYD G CANTLEY
    • 依托单位:
    海外基金